These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28381169)

  • 21. Physiological and pathological actions of sphingosine 1-phosphate.
    Hla T
    Semin Cell Dev Biol; 2004 Oct; 15(5):513-20. PubMed ID: 15271296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Death and taxis: what non-mammalian models tell us about sphingosine-1-phosphate.
    Oskouian B; Saba JD
    Semin Cell Dev Biol; 2004 Oct; 15(5):529-40. PubMed ID: 15271298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate.
    Gomez-Muñoz A; Presa N; Gomez-Larrauri A; Rivera IG; Trueba M; Ordoñez M
    Prog Lipid Res; 2016 Jan; 61():51-62. PubMed ID: 26703189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sphingosine 1-phosphate and sphingosine kinase activity during chicken embryonic development.
    Choi CH; Jeong JS; Yoo BI; Jin YX; Moon DC; Yoo HS; Oh S; Hong SP; Lee YM
    Arch Pharm Res; 2007 Apr; 30(4):502-6. PubMed ID: 17489368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical methods for quantifying sphingolipids: ceramide, sphingosine, sphingosine kinase-1 activity, and sphingosine-1-phosphate.
    Brizuela L; Cuvillier O
    Methods Mol Biol; 2012; 874():1-20. PubMed ID: 22528435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics.
    Milstien S; Spiegel S
    Cancer Cell; 2006 Mar; 9(3):148-50. PubMed ID: 16530698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First evidence of SGPL1 expression in the cell membrane silencing the extracellular S1P siren in mammary epithelial cells.
    Engel N; Adamus A; Frank M; Kraft K; Kühn J; Müller P; Nebe B; Kasten A; Seitz G
    PLoS One; 2018; 13(5):e0196854. PubMed ID: 29718989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine 1-phosphate: a potential molecular target for ovarian cancer therapy?
    Dai L; Xia P; Di W
    Cancer Invest; 2014 Mar; 32(3):71-80. PubMed ID: 24499107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sphingosine-1-Phosphate (S1P)-Related Response of Human Conjunctival Fibroblasts After Filtration Surgery for Glaucoma.
    Aoyama-Araki Y; Honjo M; Uchida T; Yamagishi R; Kano K; Aoki J; Aihara M
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2258-2265. PubMed ID: 28418499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial sphingosine kinase/SPNS2 axis is critical for vessel-like formation by human mesoangioblasts.
    Laurenzana A; Cencetti F; Serratì S; Bruno G; Japtok L; Bianchini F; Torre E; Fibbi G; Del Rosso M; Bruni P; Donati C
    J Mol Med (Berl); 2015 Oct; 93(10):1145-57. PubMed ID: 25952146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Progress in the study of physiological function of sphingosine 1-phosphate].
    Duan HF; Wang LS; Wu C
    Sheng Li Ke Xue Jin Zhan; 2003 Jan; 34(1):16-20. PubMed ID: 12778803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphingosin 1-phosphate contributes in tumor progression.
    Tabasinezhad M; Samadi N; Ghanbari P; Mohseni M; Saei AA; Sharifi S; Saeedi N; Pourhassan A
    J Cancer Res Ther; 2013; 9(4):556-63. PubMed ID: 24518696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog.
    Yonesu K; Kawase Y; Inoue T; Takagi N; Tsuchida J; Takuwa Y; Kumakura S; Nara F
    Biochem Pharmacol; 2009 Mar; 77(6):1011-20. PubMed ID: 19150609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of vascular permeability by sphingosine 1-phosphate.
    Wang L; Dudek SM
    Microvasc Res; 2009 Jan; 77(1):39-45. PubMed ID: 18973762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sphingosine 1-phosphate in neural signalling and function.
    Milstien S; Gude D; Spiegel S
    Acta Paediatr; 2007 Apr; 96(455):40-3. PubMed ID: 17391440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential.
    Aoki M; Aoki H; Ramanathan R; Hait NC; Takabe K
    Mediators Inflamm; 2016; 2016():8606878. PubMed ID: 26966342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression.
    Murph M; Mills GB
    Expert Rev Mol Med; 2007 Oct; 9(28):1-18. PubMed ID: 17935635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of Tumor Immune Microenvironment by Sphingolipids and Lysophosphatidic Acid.
    Vishwakarma S; Arya N; Kumar A
    Curr Drug Targets; 2022; 23(6):559-573. PubMed ID: 34879798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.
    Samadi N; Bekele R; Capatos D; Venkatraman G; Sariahmetoglu M; Brindley DN
    Biochimie; 2011 Jan; 93(1):61-70. PubMed ID: 20709140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Independence of tumor necrosis factor-alpha-induced adhesion molecule expression from sphingosine 1-phosphate signaling in vascular endothelial cells.
    Miura Y; Yatomi Y; Ohmori T; Osada M; Ozaki Y
    J Thromb Haemost; 2004 Jun; 2(6):1019-21. PubMed ID: 15140149
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.